Semaglutide is a GLP-1 receptor agonist, originally developed for managing type 2 diabetes. However, it has proven to be highly effective in weight loss programs as well. Read More…..
Tirzepatide, marketed under the brand name Mounjaro, is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptor agonist. Read more …
Embarking on a weight loss program can be challenging, but with the right plan, it’s entirely achievable. A structured 12-week weight loss plan can help you not only lose excess weight but also improve your overall mental health. Read more…..
Ozempic (semaglutide) has gained attention for its effectiveness in weight loss, particularly in people who are overweight or have obesity. It was initially developed for managing type 2 diabetes, but studies have shown that it can significantly support weight loss by helping to regulate appetite and reduce food cravings.
For someone looking to lose around 10 kg, Ozempic could be quite effective depending on various factors, including lifestyle changes such as diet and exercise. In clinical trials, individuals who took Ozempic experienced an average weight loss of 10-15% of their body weight over a period of 6 to 12 months, which suggests it could be useful for a 10 kg target.
However, results vary from person to person. Some key points to consider are:
Ozempic is generally recommended for individuals with a BMI over 27 (with comorbid conditions) or a BMI over 30, so it’s important to consult with a healthcare provider to determine if it’s suitable for your goals.